Found: 12
Select item for more details and to access through your institution.
Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1).
- Published in:
- Oncogene, 1999, v. 18, n. 42, p. 5814, doi. 10.1038/sj.onc.1202975
- By:
- Publication type:
- Article
Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts.
- Published in:
- Oncogene, 1999, v. 18, n. 23, p. 3520, doi. 10.1038/sj.onc.1202716
- By:
- Publication type:
- Article
pHUSH: a single vector system for conditional gene expression.
- Published in:
- BMC Biotechnology, 2007, v. 7, p. 1, doi. 10.1186/1472-6750-7-61
- By:
- Publication type:
- Article
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents.
- Published in:
- Journal of Cell Biology, 2008, v. 183, n. 1, p. 101, doi. 10.1083/jcb.200801099
- By:
- Publication type:
- Article
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
- Published in:
- Nature, 2010, v. 464, n. 7287, p. 431, doi. 10.1038/nature08833
- By:
- Publication type:
- Article
P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 606, doi. 10.1093/jnci/djt054
- By:
- Publication type:
- Article
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036402
- By:
- Publication type:
- Article
Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005717
- By:
- Publication type:
- Article
Erratum: Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.
- Published in:
- Nature, 2013, v. 502, n. 7470, p. 258, doi. 10.1038/nature12659
- By:
- Publication type:
- Article
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.
- Published in:
- Nature, 2013, v. 501, n. 7466, p. 232, doi. 10.1038/nature12441
- By:
- Publication type:
- Article
Targeting cancer with kinase inhibitors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Requirement for glycogen synthase kinase-3beta in cell survival and NF-KB activation.
- Published in:
- Nature, 2000, v. 406, n. 6791, p. 86, doi. 10.1038/35017574
- By:
- Publication type:
- Article